Legal
Filter News
Found 8,924 articles
-
Citing “sources familiar with the matter,” The Wall Street Journal reported that the agreement, should it be reached, would ultimately settle the matter for the company related to sales of Duragesic and Nucynta.
-
Netherlands-based Pharming Group NV has denied any involvement in a potential theft of intellectual property belonging to CSL Behring from Joseph Chiao, who recently joined Pharming as medical director.
-
China Biologic Special Committee Retains Financial Advisor and Legal Counsel
10/17/2019
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the special committee (the "Special Committee") of the Company's board of directors (the "Board") has retained Duff & Phelps, LLC and Duff & Phelps Securities, LLC as its financial advisor and Davis Polk & Wardwell LLP
-
Moore Kuehn, PLLC Encourages Genomic Health, Inc. and Carbonite, Inc. Investors to Contact Firm
10/17/2019
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law related to merger agreements, inaccurate developments and/or financial projections.
-
AmerisourceBergen, McKesson and Cardinal Health are in the midst of negotiations for a multi-billion settlement over litigation filed against each of the companies for their role in distributing opioid drugs across the country.
-
PixarBio CEO Made Wild Claims About Curing Paralysis, According to a Former Executive's Testimony
10/16/2019
Frank Reynolds, chief executive officer of PixarBio, made outlandish claims to investors and even compared himself to Apple’s Steve Jobs and Jesus Christ. Those were the claims of a witness made on the witness stand in an ongoing securities fraud trial. -
Pharming responds to press speculation
10/16/2019
Pharming categorically denies having had any involvement in the alleged abstraction of proprietary information by Dr Joseph Chiao from his former employer CSL
-
ImmunoCellular Therapeutics Announces Settlement of Derivative Action Lawsuit
10/16/2019
The Court approved the settlement amount of one hundred forty-five thousand dollars ($145,000.00) to be paid by ImmunoCellular's insurer to Plaintiff's Counsel, and for a Service Award of one thousand dollars ($1,000.00) to be paid to Plaintiff from the Fee and Expense Award.
-
Los Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward
10/16/2019
Sorrento Therapeutics, Inc. announced today that a Los Angeles Superior Court judge has rejected Patrick Soon-Shiong’s attempt to allow him and his company, NantPharma, to avoid the billion-dollar fraud and breach of contract claims that Sorrento filed against them earlier this year.
-
Titan Medical Announces Filing of Amended and Restated Preliminary Prospectus and Withdrawal of Previously Published Milestones
10/15/2019
The A&R Preliminary Prospectus and Registration Statement are subject to completion and amendment.
-
MedX Holdings, Inc. (MEDH) Announces New Asset Acquisition
10/15/2019
MedX Holdings, Inc. is pleased to announce the acquisition of BioHydro LLC.
-
SCYNEXIS to Strengthen its Balance Sheet with Non-Dilutive Funding Through the New Jersey Economic Development Authority Net Operating Loss and R&D Tax Credits Program
10/10/2019
SCYNEXIS, Inc. has received notification from the State of New Jersey of its available unused net operating losses (NOLs) and R&D tax credits that can be sold under the New Jersey Economic Development Authority's (NJEDA) Technology Business Tax Certificate Transfer (NOL) program.
-
SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra Pharmaceuticals, Inc.
10/10/2019
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Ra Pharmaceuticals, Inc. in connection with the proposed acquisition of the Company by UCB S.A.
-
Lawsuit Settlement News Announces Assistance for Plaintiffs in Roundup Weed Killer Lawsuits
10/10/2019
Premier mass tort servicing firm available to help plaintiffs find a lawyer or seek lawsuit funding from their Bayer Monsanto case
-
The jury found the company failed to warn patients of a side effect causing young men who used the drug to grow breasts (gynecomastia).
-
Acorda Therapeutics’ attempt to preserve its patent protection for multiple sclerosis drug Ampyra hit the proverbial wall Monday when the U.S. Supreme Court refused to hear the company’s appeal of a lower court ruling.
-
Governor Signs Bipartisan Bill To Extend Funding For Emergency Air Medical Services
10/8/2019
Governor Gavin Newsom has signed legislation that ensures Californians are not left without emergency air medical services when a state funding source sunsets in December.
-
Patent Suit Against Sonitor Expands
10/8/2019
CenTrak, Inc., the global leader in Real-Time Location Systems, announces the recent addition of three RTLS related patents, US Patent Nos. 8,907,754, 9,622,030, and 10,126,407, to its ongoing dispute with Sonitor Technologies, Inc.
-
RNs at Steward Nashoba Valley Medical Center Overwhelmingly Ratify New Three-Year Contract
10/8/2019
Enhancements in wages and nurse-staffing levels expected to improve nurse recruitment and retention, as well as the quality of patient care
-
Bayer Supports Federal Employment Protection for LGBT+ Employees
10/8/2019
The Supreme Court of the United States will be reviewing three cases (Altitude Express, Inc. v. Zarda; Bostock v. Clayton County; and R.G. & G.R. Harris Funeral Homes, Inc. v. EEOC) that take up the question of whether employment discrimination based on sexual orientation or gender identity is prohibited by Title VII of the Civil Rights Act of 1964.